Literature DB >> 7706490

Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

C Guo1, B Van Damme, Y Vanrenterghem, K Devriendt, J J Cassiman, P Marynen.   

Abstract

The X-linked form of Alport disease, caused by mutations in the COL4A5 or the COL4A6 gene, usually leads to terminal renal failure in males, while affected females have a more variable and moderate phenotype. We detected in a female patient, with a severe Alport phenotype, two new missense mutations. One mutation (G289V) occurred in exon 15 and converted a glycine in a collagenous domain of COL4A5 to a valine. The second mutation, located in exon 46, substituted a cysteine proximal to the NC1 domain of COL4A5 for an arginine. In white blood cells and kidney both mutations were present on > 90% of the mRNA, while at the genomic level the patient was heterozygous for both mutations. The two mutations therefore occurred in the same COL4A5 allele. No mutation was found in the COL4A5 promoter region by sequencing nor was a major rearrangement of the normal allele detected. A skewed pattern of X inactivation was demonstrated in DNA isolated from the patient's kidney and white blood cells: > 90% of the X chromosomes with the normal COL4A5 allele was inactivated. It is suggested that this skewed inactivation pattern is responsible for the absence of detectable normal COL4A5 mRNA and hence the severe phenotype in this woman.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706490      PMCID: PMC295718          DOI: 10.1172/JCI117862

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  An efficient salt-chloroform extraction of DNA from blood and tissues.

Authors:  R Müllenbach; P J Lagoda; C Welter
Journal:  Trends Genet       Date:  1989-12       Impact factor: 11.639

2.  Different patterns of X inactivation in MZ twins discordant for red-green color-vision deficiency.

Authors:  A L Jørgensen; J Philip; W H Raskind; M Matsushita; B Christensen; V Dreyer; A G Motulsky
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Mutation in the alpha 5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: detection by denaturing gradient gel electrophoresis of a PCR product.

Authors:  J Zhou; J M Hertz; K Tryggvason
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

4.  The structural genes for alpha 1 and alpha 2 chains of human type IV collagen are divergently encoded on opposite DNA strands and have an overlapping promoter region.

Authors:  R Soininen; M Huotari; S L Hostikka; D J Prockop; K Tryggvason
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

5.  The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism.

Authors:  E B Hook; D Warburton
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Characterization of the 3' half of the human type IV collagen alpha 5 gene that is affected in the Alport syndrome.

Authors:  J Zhou; S L Hostikka; L T Chow; K Tryggvason
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

7.  The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen.

Authors:  B Siebold; R Deutzmann; K Kühn
Journal:  Eur J Biochem       Date:  1988-10-01

8.  Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient.

Authors:  J Zhou; J M Hertz; A Leinonen; K Tryggvason
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

9.  Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments.

Authors:  B Knebelmann; G Deschenes; F Gros; M C Hors; J P Grünfeld; J Zhou; K Tryggvason; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

10.  Renal prognosis in women with hereditary nephritis.

Authors:  J P Grünfeld; L H Noël; S Hafez; D Droz
Journal:  Clin Nephrol       Date:  1985-06       Impact factor: 0.975

View more
  14 in total

1.  Female X-linked Alport syndrome with somatic mosaicism.

Authors:  Kana Yokota; Kandai Nozu; Shogo Minamikawa; Tomohiko Yamamura; Keita Nakanishi; Hisashi Kaneda; Riku Hamada; Yoshimi Nozu; Akemi Shono; Takeshi Ninchoji; Naoya Morisada; Shingo Ishimori; Junya Fujimura; Tomoko Horinouchi; Hiroshi Kaito; Koichi Nakanishi; Ichiro Morioka; Mariko Taniguchi-Ikeda; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2016-10-31       Impact factor: 2.801

2.  Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.

Authors:  Koei Ikeda; Ken-ichi Iyama; Nobuyuki Ishikawa; Hiroshi Egami; Mitsuyoshi Nakao; Yoshikazu Sado; Yoshifumi Ninomiya; Hideo Baba
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome.

Authors:  B Knebelmann; C Breillat; L Forestier; C Arrondel; D Jacassier; I Giatras; L Drouot; G Deschênes; J P Grünfeld; M Broyer; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

4.  X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.

Authors:  Michelle N Rheault; Stefan M Kren; Linda A Hartich; Melanie Wall; William Thomas; Hector A Mesa; Philip Avner; George E Lees; Clifford E Kashtan; Yoav Segal
Journal:  Nephrol Dial Transplant       Date:  2009-10-23       Impact factor: 5.992

Review 5.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

Review 6.  Women and Alport syndrome.

Authors:  Michelle N Rheault
Journal:  Pediatr Nephrol       Date:  2011-03-05       Impact factor: 3.714

7.  A Novel Mutation in a Japanese Family with X-linked Alport Syndrome.

Authors:  Yoshifusa Abe; Masayuki Iyoda; Kandai Nozu; Satoshi Hibino; Kei Hihara; Yutaka Yamaguchi; Tomohiko Yamamura; Shogo Minamikawa; Kazumoto Iijima; Takanori Shibata; Kazuo Itabashi
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

8.  A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities.

Authors:  Chan Zhao; Fang Wang; Yanqin Zhang; Yubing Wen; Ying Su; Chengfen Zhang; Ruifang Sui; Fei Xu; Jie Ding; Fangtian Dong
Journal:  Mol Vis       Date:  2012-08-08       Impact factor: 2.367

9.  Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine.

Authors:  Pilar Antón-Martín; Cristina Aparicio López; Soraya Ramiro-León; Sonia Santillán Garzón; Fernando Santos-Simarro; Belén Gil-Fournier
Journal:  Clin Med Insights Pediatr       Date:  2012-06-28

10.  The variable course of women with X-linked Alport Syndrome.

Authors:  Priya Raju; David Cimbaluk; Stephen M Korbet
Journal:  Clin Kidney J       Date:  2013-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.